Facebook
Twitter
LinkedIn
ForwardOpportunities for Intervention in the Week Preceding a Sepsis Hospitalization | Multidisciplinary Approach to Bugs & Drugs: Deciding When and What Antimicrobials to Use in Adult Sepsis Patients
Session Descriptions:
This activity includes two sessions from Sepsis Alliance Summit to meet the minimum time requirement for nursing CE credits.
Opportunities for Intervention in the Week Preceding a Sepsis Hospitalization
This session will review patient encounters with the healthcare system in the week preceding a sepsis hospitalization. Encounters in the seven days prior to a sepsis admission often present valuable opportunities for intervention and for preventing the transition from infection to sepsis. Learners will review data on the frequency and types of encounters common ahead of a sepsis admission, discuss whether these high-risk patients can be identified during these encounters, and discover advances in care and screening with the potential to prevent sepsis hospitalization or identify decompensation earlier.
Multidisciplinary Approach to Bugs & Drugs: Deciding When and What Antimicrobials to Use in Adult Sepsis Patients
According to the Centers for Disease Control & Prevention (CDC), antimicrobial resistance is an urgent global public health threat associated with nearly 5 million deaths worldwide in 2019 alone. In the U.S., more than 2.8 million antimicrobial-resistant infections occur each year. If antimicrobials like antibiotics, antivirals, and antifungals lose their efficacy, our ability to treat infections and sepsis will erode significantly. Robust antimicrobial stewardship is therefore key to managing this public health threat.
In this session, the presenters will discuss the importance of a multidisciplinary approach to optimizing timely antimicrobial selection in sepsis patients. They will also review important considerations involving individual patient histories, infection sources, and resistance patterns, as well as appropriate follow-up and de-escalation strategies for healthcare professionals to apply in practice.
Target Audience
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Learning Objectives
At the end of the session, the learner should be able to:
Opportunities for Intervention in the Week Preceding a Sepsis Hospitalization
Identify the characteristics of patients who have an encounter with the healthcare system in the week preceding a sepsis hospitalization;
Examine possible interventions for preventing the development, or lessening the severity, of sepsis in this patient population.
Multidisciplinary Approach to Bugs & Drugs: Deciding When and What Antimicrobials to Use in Adult Sepsis Patients
- Describe the importance of a multidisciplinary approach to optimal selection of antimicrobial therapy in the treatment of sepsis;
- Recognize the appropriate time to initiate antimicrobial therapy in sepsis patients;
- Consider important factors such as source of infection, past medical history, and resistance patterns during selection of antimicrobial therapy;
- Develop an appropriate follow-up plan for antimicrobial therapy de-escalation and discontinuation.
Alexander H. Flannery, Pharm.D., Ph.D., FCCM, FCCP, FASHP, BCCCP, BCPS
Assistant Professor, Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy
Alexander Flannery, Pharm.D., Ph.D., FCCM, FCCP, FASHP, BCCCP, BCPS, received his Doctor of Pharmacy degree from the University of Kentucky, followed by completion of a PGY1 pharmacy practice residency at the Medical University of South Carolina and a PGY2 critical care specialty residency at the University of Kentucky.
Dr. Flannery's clinical and translational research program focuses on sepsis and acute kidney injury with an emphasis on biologic and molecular observations from human disease, to gain a better understanding of the underlying pathophysiology. He works collaboratively to develop improved pre-clinical and clinical approaches to treatment based on this information.
Dr. Flannery coordinates Evidence-Based Medicine and Clinical Reasoning courses, among other teaching activities at the University of Kentucky College of Pharmacy. He maintains an active practice site in the Medical Intensive Care Unit at UK HealthCare. He is an active member of the American College of Clinical Pharmacy and the Society of Critical Care Medicine, where he is recognized as a Fellow in the American College of Critical Care Medicine.
Hend Barry, PharmD, BCPS, BCCCP
Lead Clinical Pharmacist, Swedish Medical Center, Ballard
Hend Barry, PharmD, BCPS, BCCCP, is currently working as an Emergency Department Clinical Pharmacy Specialist at Swedish Medical Center. She also serves as the Clinical Lead Pharmacist for the Ballard campus and is part of the seven-pharmacist Clinical Pharmacy Committee, which oversees all the Swedish Medical Center clinical activities. Dr. Barry received her Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences and completed her PGY-1 Pharmacy Practice Residency at the University Medical Center of Southern Nevada. She then went on to work at Sunrise Hospital and Medical Center Emergency Department (165,000 visits per year) and was heavily involved in trauma activations (level I – IV), the sepsis program, and ED protocol optimization. She spends her time off traveling with her family to beach destinations around the world.
Kathy E. Currie, PharmD, BCPS
Clinical Pharmacist, Providence Regional Medical Center Everett
Kathy Currie, PharmD, BCPS, grew up in Puerto Rico but is now far from home as a Clinical Pharmacist at Providence Regional Medical Center Everett. Dr. Currie plans to specialize in emergency medicine and critical care, her areas of interest. In 2020 she graduated with honors from the University of Washington with a Doctor of Pharmacy and in 2021 she completed a Pharmacy Practice Residency at Swedish Medical Center. During her residency, Dr. Currie conducted a research project focused on optimization of sepsis care within the Emergency Department. In her free time, Dr. Currie likes to cook, travel, and spend time with her husband and dog.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.4 contact hours.
Other healthcare providers will receive a certificate of attendance for 1.0 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Available Credit
- 1.00 Participation
- 1.40 RN CE Contact HoursProvider approved by the California Board of Registered Nursing, Provider Number CEP17068.